ALBO insider filings

ALBIREO PHARMA, INC. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-03-03. Screen ALBO transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for ALBO between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — ALBIREO PHARMA, INC.

FiledFormInsiderReported transactionsSource
2023-03-034Chiswell David — DirectorCode (U): 56,278 · Disposition to issuer (D): 8,000 (derivative) · Disposition to issuer (D): 8,000 (derivative) · Disposition to issuer (D): 8,000 (derivative) · Disposition to issuer (D): 5,500 (derivative) · Disposition to issuer (D): 5,500 (derivative) · +2 moreEDGAR
2023-03-024Alesina Susan — DirectorDisposition to issuer (D): 16,000 (derivative)EDGAR
2023-03-024Okey Stephanie — DirectorDisposition to issuer (D): 8,000 (derivative) · Disposition to issuer (D): 8,000 (derivative) · Disposition to issuer (D): 8,000 (derivative) · Disposition to issuer (D): 5,500 (derivative) · Disposition to issuer (D): 5,500 (derivative) · Disposition to issuer (D): 11,000 (derivative)EDGAR
2023-03-024Harford Simon N.R. — CFO and TreasurerCode (U): 13,739 · Disposition to issuer (D): 23,700 (derivative) · Disposition to issuer (D): 31,500 (derivative) · Disposition to issuer (D): 31,500 (derivative) · Disposition to issuer (D): 37,500 (derivative) · Disposition to issuer (D): 73,950 (derivative)EDGAR
2023-03-024Cooper Ronald Harold Wilfred — President and CEO, DirectorCode (U): 33,094 · Disposition to issuer (D): 132,150 (derivative) · Disposition to issuer (D): 43,027 (derivative) · Disposition to issuer (D): 93,000 (derivative) · Disposition to issuer (D): 124,000 (derivative) · Disposition to issuer (D): 124,000 (derivative) · +5 moreEDGAR
2023-03-024STRECK PAUL — Chief Medical OfficerDisposition to issuer (D): 118,966 (derivative)EDGAR
2023-03-024Stephenson Pamela — Chief Commercial OfficerCode (U): 22,242 · Disposition to issuer (D): 23,700 (derivative) · Disposition to issuer (D): 31,500 (derivative) · Disposition to issuer (D): 37,500 (derivative) · Disposition to issuer (D): 75,513 (derivative)EDGAR
2023-03-024Graham Michelle — Chief Human Resources OfficerCode (U): 5,543 · Disposition to issuer (D): 23,700 (derivative) · Disposition to issuer (D): 31,500 (derivative) · Disposition to issuer (D): 37,500 (derivative) · Disposition to issuer (D): 50,950 (derivative)EDGAR
2023-03-024Gutch Michael — DirectorDisposition to issuer (D): 8,000 (derivative) · Disposition to issuer (D): 8,000 (derivative) · Disposition to issuer (D): 8,000 (derivative) · Disposition to issuer (D): 5,500 (derivative) · Disposition to issuer (D): 5,500 (derivative) · Disposition to issuer (D): 3,000 (derivative) · +1 moreEDGAR
2023-03-024Duncan Jason — Chief Legal Officer and GCCode (U): 3,296 · Disposition to issuer (D): 15,900 (derivative) · Disposition to issuer (D): 10,063 (derivative) · Disposition to issuer (D): 24,337 (derivative) · Disposition to issuer (D): 23,700 (derivative) · Disposition to issuer (D): 37,500 (derivative) · +1 moreEDGAR
2023-03-024Mattsson Jan — Chief Scientific OfficerCode (U): 35,524 · Disposition to issuer (D): 23,700 (derivative) · Disposition to issuer (D): 31,500 (derivative) · Disposition to issuer (D): 31,500 (derivative) · Disposition to issuer (D): 40,000 (derivative) · Disposition to issuer (D): 13,000 (derivative) · +2 moreEDGAR
2023-03-024Dable Habib J — DirectorDisposition to issuer (D): 16,000 (derivative)EDGAR
2023-03-024Hopkinson Craig C. — DirectorDisposition to issuer (D): 10,495 (derivative)EDGAR
2023-03-024SCOON DAVEY — DirectorDisposition to issuer (D): 8,000 (derivative) · Disposition to issuer (D): 8,000 (derivative) · Disposition to issuer (D): 8,000 (derivative) · Disposition to issuer (D): 5,500 (derivative) · Disposition to issuer (D): 5,500 (derivative) · Disposition to issuer (D): 3,000 (derivative) · +3 moreEDGAR
2023-03-024Carter Martha J. — Chief Regulatory OfficerCode (U): 3,656 · Disposition to issuer (D): 15,900 (derivative) · Disposition to issuer (D): 23,700 (derivative) · Disposition to issuer (D): 3,250 (derivative) · Disposition to issuer (D): 62,009 (derivative) · Disposition to issuer (D): 2,500 (derivative) · +4 moreEDGAR
2023-01-274/ACooper Ronald Harold Wilfred — President and CEO, DirectorGrant/award (A): 195,000 @ $0EDGAR
2023-01-274/AMattsson Jan — Chief Scientific OfficerGrant/award (A): 55,000 @ $0EDGAR
2023-01-274/ADuncan Jason — Chief Legal Officer and GCGrant/award (A): 55,000 @ $0EDGAR
2023-01-274/AGraham Michelle — Chief Human Resources OfficerGrant/award (A): 32,000 @ $0EDGAR
2023-01-274/AHarford Simon N.R. — CFO and TreasurerGrant/award (A): 55,000 @ $0EDGAR
2023-01-274/AStephenson Pamela — Chief Commercial OfficerGrant/award (A): 55,000 @ $0EDGAR
2023-01-274/ASTRECK PAUL — Chief Medical OfficerGrant/award (A): 55,000 @ $0EDGAR
2023-01-274/ACarter Martha J. — Chief Regulatory OfficerGrant/award (A): 55,000 @ $0EDGAR
2023-01-254Cooper Ronald Harold Wilfred — President and CEO, DirectorGrant/award (A): 195,000 @ $0EDGAR
2023-01-254Mattsson Jan — Chief Scientific OfficerGrant/award (A): 55,000 @ $0EDGAR
2023-01-254Duncan Jason — Chief Legal Officer and GCGrant/award (A): 55,000 @ $0EDGAR
2023-01-254Graham Michelle — Chief Human Resources OfficerGrant/award (A): 32,000 @ $0EDGAR
2023-01-254Harford Simon N.R. — CFO and TreasurerGrant/award (A): 55,000 @ $0EDGAR
2023-01-254Stephenson Pamela — Chief Commercial OfficerGrant/award (A): 55,000 @ $0EDGAR
2023-01-254STRECK PAUL — Chief Medical OfficerGrant/award (A): 55,000 @ $0EDGAR
2023-01-254Carter Martha J. — Chief Regulatory OfficerGrant/award (A): 55,000 @ $0EDGAR
2023-01-234Stephenson Pamela — Chief Commercial OfficerSale (S): 102 @ $43.80EDGAR
2023-01-234Graham Michelle — Chief Human Resources OfficerSale (S): 102 @ $43.80EDGAR
2023-01-234Mattsson Jan — Chief Scientific OfficerSale (S): 197 @ $43.80EDGAR
2023-01-234Harford Simon N.R. — CFO and TreasurerSale (S): 102 @ $43.80EDGAR
2023-01-234Duncan Jason — Chief Legal Officer and GCSale (S): 228 @ $43.80EDGAR
2023-01-234Cooper Ronald Harold Wilfred — President and CEO, DirectorSale (S): 1,057 @ $43.80EDGAR
2023-01-234Carter Martha J. — Chief Regulatory OfficerSale (S): 120 @ $43.80EDGAR
2023-01-204Stephenson Pamela — Chief Commercial OfficerSale (S): 1,774 @ $43.90EDGAR
2023-01-204Duncan Jason — Chief Legal Officer and GCSale (S): 938 @ $43.90EDGAR
2023-01-204Mattsson Jan — Chief Scientific OfficerSale (S): 3,088 @ $43.80EDGAR
2023-01-204Graham Michelle — Chief Human Resources OfficerSale (S): 1,774 @ $43.90EDGAR
2023-01-204Harford Simon N.R. — CFO and TreasurerSale (S): 1,776 @ $43.80EDGAR
2023-01-204Carter Martha J. — Chief Regulatory OfficerSale (S): 938 @ $43.90EDGAR
2023-01-094/AStephenson Pamela — Chief Commercial OfficerSale (S): 469 @ $19.06EDGAR
2023-01-094/AStephenson Pamela — Chief Commercial OfficerSale (S): 106 @ $24.67EDGAR
2023-01-094/ACooper Ronald Harold Wilfred — President and CEO, DirectorSale (S): 919 @ $19.58EDGAR
2022-12-274Stephenson Pamela — Chief Commercial OfficerSale (S): 469 @ $19.06EDGAR
2022-12-214STRECK PAUL — Chief Medical OfficerGrant/award (A): 63,966 @ $0EDGAR
2022-12-054Hopkinson Craig C. — DirectorGrant/award (A): 10,495 @ $0EDGAR

Recent 8-K events — ALBIREO PHARMA, INC.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2023-03-028-K2.01 — Completion of Acquisition or Disposition of Assets
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
3.03 — Material Modification to Rights of Security Holders
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2023-02-148-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2023-01-098-K1.01 — Entry into a Material Definitive Agreement
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2022-12-068-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2022-11-088-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2022-10-118-K2.02 — Results of Operations and Financial Condition
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2022-09-228-K1.01 — Entry into a Material Definitive Agreement
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2022-08-228-K/A5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2022-08-168-K1.01 — Entry into a Material Definitive Agreement
1.02 — Termination of a Material Definitive Agreement
EDGAR
2022-08-158-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=ALBO returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs